Radiotherapy for brain metastases from small-cell lung cancer in distinct clinical indications and scenarios

Management of brain metastases (BM) from small-cell lung cancer (SCLC) is complex and not supported by a strong evidence from prospective clinical trials. Owing to the different clinical and pathological characteristics of SCLC, patients with this histology were not included in the prospective studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kepka, Lucyna, Socha, Joanna, Sas-Korczynska, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Radiotherapy for Brain Metastases from Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182529/
https://www.ncbi.nlm.nih.gov/pubmed/34164219
http://dx.doi.org/10.21037/jtd.2019.10.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182529/
https://www.ncbi.nlm.nih.gov/pubmed/34164219
http://dx.doi.org/10.21037/jtd.2019.10.51

Ejemplares similares